2022. ESTIMATION OF ROLE OF HYPERHOMOCYSTEINEMIA, BIOCHEMICAL PARAMETERS , AND CLINICAL MARKERS IN ATHEROSCLEROSIS PATIENTS IN AL-NAJAF AL-ASHRAF GOVERNORATE. Journal of Pharmaceutical Negative Results. (Oct. 2022), 1585–1591. DOI:https://doi.org/10.47750/pnr.2022.13.S01.189.